Wolff Wiese Magana’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.8K Hold
149
0.01% 379
2026
Q1
$20.8K Hold
149
0.01% 320
2025
Q4
$18.3K Hold
149
0.01% 327
2025
Q3
$16.5K Hold
149
0.01% 354
2025
Q2
$16.5K Sell
149
-30
-17% -$3.19K 0.01% 319
2025
Q1
$20.1K Buy
179
+49
+38% +$5.06K 0.01% 292
2024
Q4
$12K Hold
130
0.01% 391
2024
Q3
$10.9K Hold
130
0.01% 429
2024
Q2
$8.92K Hold
130
0.01% 343
2024
Q1
$9.52K Hold
130
0.01% 301
2023
Q4
$10.5K Sell
130
-16
-11% -$1.25K 0.01% 277
2023
Q3
$10.9K Hold
146
0.01% 339
2023
Q2
$11.3K Sell
146
-150
-51% -$12K 0.01% 333
2023
Q1
$24.6K Buy
296
+100
+51% +$8.28K 0.02% 248
2022
Q4
$16.8K Hold
196
0.01% 279
2022
Q3
$12K Hold
196
0.01% 475
2022
Q2
$12K Buy
196
+25
+15% +$1.55K 0.01% 501
2022
Q1
$10K Hold
171
0.01% 538
2021
Q4
$12K Hold
171
0.01% 514
2021
Q3
$12K Sell
171
-30
-15% -$2.11K 0.01% 498
2021
Q2
$14K Buy
201
+30
+18% +$2K 0.01% 447
2021
Q1
$11K Sell
171
-618
-78% -$39.8K 0.01% 462
2020
Q4
$46K Buy
+789
New +$47.6K 0.04% 274

Other funds holding GILD

Wolff Wiese Magana's GILD Position: Q2 2026 in Review

Wolff Wiese Magana held its Gilead Sciences (GILD) position steady in Q2 2026 at 149 shares worth $18.8K. The position accounts for 0.01% of the portfolio, ranked #379.

Wolff Wiese Magana first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $46K in Q4 2020. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Wolff Wiese Magana held 149 shares of Gilead Sciences worth $18.8K as of Q2 2026.
  • Wolff Wiese Magana left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #379 holding.
  • Wolff Wiese Magana first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • Wolff Wiese Magana's Gilead Sciences position peaked at $46K in Q4 2020.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.